
Penumbra PEN
$ 322.23
-0.75%
Quarterly report 2026-Q1
added 05-06-2026
Penumbra Total Liabilities 2011-2026 | PEN
Annual Total Liabilities Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 399 M | 382 M | 377 M | 372 M | 290 M | 185 M | 180 M | 92.6 M | 76.3 M | 41.7 M | 31.3 M | 134 M | 79.2 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 399 M | 31.3 M | 203 M |
Quarterly Total Liabilities Penumbra
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 425 M | 386 M | 381 M | 380 M | 375 M | 373 M | 376 M | 364 M | 366 M | 371 M | 372 M | 348 M | - | 342 M | 290 M | 289 M | - | 190 M | 185 M | 185 M | 185 M | 185 M | 180 M | 180 M | 180 M | 180 M | 92.6 M | 92.6 M | 92.6 M | 92.6 M | 76.3 M | 76.3 M | 76.3 M | 76.3 M | 41.7 M | 41.7 M | 41.7 M | 41.7 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 22.3 M | 22.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 425 M | 22.3 M | 193 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.13 | -0.72 % | $ 155 M | ||
|
Apyx Medical Corporation
APYX
|
52 M | $ 3.67 | 3.09 % | $ 151 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 7.52 | -2.97 % | $ 1.13 B | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.22 | 3.26 % | $ 1.35 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.81 | 1.37 % | $ 418 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.64 | 7.84 % | $ 67.4 M | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 12.82 | 9.76 % | $ 363 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.61 | -0.08 % | $ 38 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 71.86 | 1.32 % | $ 3.92 B | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 11.48 | 2.14 % | $ 411 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Orthofix Medical
OFIX
|
401 M | $ 11.65 | -3.48 % | $ 461 M | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | - | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
27.2 M | $ 0.83 | -5.05 % | $ 34.7 M | ||
|
Electromed
ELMD
|
10.6 M | $ 26.93 | 0.26 % | $ 228 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.16 | -2.0 % | $ 881 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
11 M | $ 6.85 | -4.33 % | $ 207 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 154.16 | -3.89 % | $ 10.8 B | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.35 | -2.08 % | $ 6.52 M | ||
|
Globus Medical
GMED
|
730 M | $ 77.95 | -8.37 % | $ 10.5 B | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 36.76 | -3.52 % | $ 1.14 B | ||
|
Stryker Corporation
SYK
|
25.4 B | $ 285.47 | -2.98 % | $ 109 B | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 44.26 | -2.87 % | $ 1.3 B | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 88.12 | 0.23 % | $ 3.06 B | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 79.96 | -3.44 % | $ 46.8 B | ||
|
Tandem Diabetes Care
TNDM
|
726 M | $ 15.48 | -16.19 % | $ 1.05 B |